You have 9 free searches left this month | for more free features.

Condition

Fallopian Tube Cancer (1)

Ovarian Cancer (1)

Primary Peritoneal Cancer (1)

Recurrent Fallopian Tube Cancer (1)

Recurrent Ovarian Cancer (1)

Recurrent Primary Peritoneal Cancer (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Regeneron Pharmaceuticals (2)

Collaborator

Intervention

cemiplimab (2)

regn4018 (2)

regn5668 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

regn4018

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in United States (REGN5668, Cemiplimab, REGN4018)

Recruiting

Ovarian Cancer
+2 more

REGN5668
+2 more

Duarte, California
+7 more

Sep 26, 2022

Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer Trial in Australia, Belgium,

Recruiting

Recurrent Ovarian Cancer
+2 more

REGN4018
cemiplimab

Birmingham, Alabama
+14 more

Oct 11, 2022